MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from sale of
common shares
$26,024K
Net provided by
financing activities
$24,698K
Canceled cashflow
$1,326K
Net change in cash,
cash equivalents and...
$16,436K
Canceled cashflow
$8,262K
Financing costs to issue
common shares
$1,183K
Repayment of financing
lease obligations
$143K
Accounts receivable
-$971K
Depreciation and
amortization expense
$631K
Stock-based compensation
$615K
Prepaid expenses and
other assets
-$449K
Inventories
-$64K
Equity compensation
for bonus awards and...
$32K
Net cash used in
operating activities
-$7,639K
Net cash used in
investing activities
-$613K
Effect of exchange rate
changes on cash and cash...
-$10K
Canceled cashflow
$2,762K
Change in fair value of
contingent consideration
-$5,918K
Other income, net
$146K
Change in fair value of
contingent consideration
-$5,918K
Net loss
-$4,290K
Machinery and equipment
purchases, and...
$613K
Canceled cashflow
$6,064K
Accounts payable and
accrued liabilities
-$105K
Operating lease assets and
liabilities
-$83K
Unrealized foreign
currency (gains) losses
$5K
something is missing
-$10,331K
Interest expense
-$23K
Back
Back
Cash Flow
Insight Molecular Diagnostics Inc. (IMDX)
Insight Molecular Diagnostics Inc. (IMDX)
source: myfinsight.com